Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases

被引:449
作者
Kawabuchi, M
Satomi, Y
Takao, T
Shimonishi, Y
Nada, S
Nagai, K
Tarakhovsky, A
Okada, M
机构
[1] Osaka Univ, Inst Prot Res, Div Prot Metab, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Inst Prot Res, Div Organ Chem, Suita, Osaka 5650871, Japan
[3] Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Div Biol Sci, Osaka 5670047, Japan
[4] Univ Cologne, Inst Genet, Lab Lymphocyte Signalling, D-50931 Cologne, Germany
关键词
D O I
10.1038/35010121
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The Src family of protein tyrosine kinases (Src-PTKs) is important in the regulation of growth and differentiation of eukaryotic cells. The activity of Src-PTKs in cells of different types is negatively controlled by Csk, which specifically phosphorylates a conserved regulatory tyrosine residue at the carboxy-terminal tail of the Src-PTKs(1-3). Csk is mainly cytoplasmic and Src-PTKs are predominantly membrane-associated. This raises a question about the mechanism of interaction between these enzymes. Here we present Cbp-a transmembrane phosphoprotein that is ubiquitously expressed and binds specifically to the SH2 domain of Csk. Cbp is involved in the membrane localization of Csk and in the Csk-mediated inhibition of c-Src. In the plasma membrane Cbp is exclusively localized in the GM1 ganglioside-enriched detergent-insoluble membrane domain, which is important in receptor-mediated signalling(4-8). These findings reveal Cbp as a new component of the regulatory mechanism controlling the activity of membrane-associated Src-PTKs.
引用
收藏
页码:999 / 1003
页数:6
相关论文
共 21 条
[1]   The caveolae membrane system [J].
Anderson, RGW .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :199-225
[2]   Functions of lipid rafts in biological membranes [J].
Brown, DA ;
London, E .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1998, 14 :111-136
[3]   Regulation, substrates and functions of src [J].
Brown, MT ;
Cooper, JA .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3) :121-149
[4]  
CLOUTIER JF, 1995, MOL CELL BIOL, V15, P5937
[5]   Ubiquitin-dependent degradation of active Src [J].
Hakak, Y ;
Martin, GS .
CURRENT BIOLOGY, 1999, 9 (18) :1039-1042
[6]   Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor - Study of Lck- and FynT-dependent T cell activation [J].
Hanke, JH ;
Gardner, JP ;
Dow, RL ;
Changelian, PS ;
Brissette, WH ;
Weringer, EJ ;
Pollok, K ;
Connelly, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :695-701
[7]   Protein-tyrosine phosphatase α regulates Src family kinases and alters cell-substratum adhesion [J].
Harder, KW ;
Moller, NPH ;
Peacock, JW ;
Jirik, FR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) :31890-31900
[8]  
Harlow E, 1988, ANTIBODIES LABORATOR, P359
[9]   CSK SUPPRESSION OF SRC INVOLVES MOVEMENT OF CSK TO SITES OF SRC ACTIVITY [J].
HOWELL, BW ;
COOPER, JA .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (08) :5402-5411
[10]  
Jensen ON, 1999, METH MOL B, V112, P513